96 related articles for article (PubMed ID: 15182952)
1. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease.
Park SW; Kim SH; Park KH; Kim SD; Kim JY; Baek SY; Chung BS; Kang CD
Neurosci Lett; 2004 Jun; 363(3):243-6. PubMed ID: 15182952
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
Pan J; Xiao Q; Sheng CY; Hong Z; Yang HQ; Wang G; Ding JQ; Chen SD
Neurochem Int; 2009 Jun; 54(7):418-25. PubMed ID: 19428783
[TBL] [Abstract][Full Text] [Related]
3. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
4. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
[TBL] [Abstract][Full Text] [Related]
5. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
6. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
Terrill JR; Boyatzis A; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
[TBL] [Abstract][Full Text] [Related]
7. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
Lee Y; Chun HJ; Lee KM; Jung YS; Lee J
Brain Res; 2015 Nov; 1627():233-42. PubMed ID: 26434409
[TBL] [Abstract][Full Text] [Related]
8. Pramipexole protects against MPTP toxicity in non-human primates.
Iravani MM; Haddon CO; Cooper JM; Jenner P; Schapira AH
J Neurochem; 2006 Mar; 96(5):1315-21. PubMed ID: 16464239
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
10. SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Wang W; Shi L; Xie Y; Ma C; Li W; Su X; Huang S; Chen R; Zhu Z; Mao Z; Han Y; Li M
Neurosci Res; 2004 Feb; 48(2):195-202. PubMed ID: 14741394
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
16. Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice.
Mu X; He GR; Yuan X; Li XX; Du GH
Pharmacol Biochem Behav; 2011 Apr; 98(2):286-91. PubMed ID: 21262257
[TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
[TBL] [Abstract][Full Text] [Related]
18. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
[TBL] [Abstract][Full Text] [Related]
20. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
